Archive: 10/04/2008

The good and bad side of anti-cancer compounds

Compounds known as “HDAC inhibitors” exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.

dateApr 10, 2008 in Cancer
shares0 comments 0